‘Stunning’ study shows twice-a-year jab could offer 100% protection against HIV infection
Lenacapavir, a new injectible HIV treatment, was given to women in South Africa and Uganda with nearly 100% efficacy. A jab given twice-yearly to treat AIDs was found to be…